Dietary L-arginine normalizes endothelin-induced vascular contractions in cholesterol-fed rabbits. 1998

L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
Institute of Clinical Pharmacology, Medical School, Hannover, Germany.

The endothelium regulates vascular function by releasing the vasodilator autacoid nitric oxide (NO) and the vasoconstrictor peptide endothelin-1 (ET-1). Impaired activity of NO as well as excessive activity of ET-1 have been demonstrated in hypercholesterolemia and atherosclerosis. Because dietary L-arginine can restore NO function and improve abnormal endothelium-dependent relaxation in hypercholesterolemic rabbits, we examined the effects of dietary supplementation with L-arginine in cholesterol-fed rabbits on endothelium-dependent vascular relaxation and ET-1-induced vascular contraction, as well as the systemic synthesis of ET-1. Rabbits were initially fed a diet enriched with 1% cholesterol for 4 weeks, followed by 0.5% cholesterol alone or supplemented with 2% L-arginine in drinking water during the next 12 weeks. Cholesterol feeding impaired endothelium-dependent relaxation of rabbit aortic rings ex vivo and increased urinary immunoreactive ET-1 excretion, along with decreased urinary nitrate excretion, an index of NO production. L-Arginine partially restored endothelium-dependent relaxation in parallel to increased urinary nitrate excretion and decreased urinary immunoreactive ET-1 excretion. Selective inhibition of ET-A receptors with BQ123 partially restored endothelium-dependent relaxation in hypercholesterolemic rabbits but had no effect on arterial rings from rabbits supplemented with L-arginine or from control animals. The contractile vascular response of aortic rings to exogenous ET-1 was increased in rabbits fed a high-cholesterol diet; this enhanced contractility to ET-1 was completely reversed by L-arginine. These data suggest that L-arginine restores endothelial function and normalizes the synthesis and vasoconstrictor response to ET-1 in hypercholesterolemia.

UI MeSH Term Description Entries
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002791 Cholesterol, Dietary Cholesterol present in food, especially in animal products. Dietary Cholesterol
D003401 Creatine An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
January 1998, Atherosclerosis,
L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
May 2011, The British journal of nutrition,
L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
December 1990, Circulation research,
L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
March 1997, Journal of the American College of Cardiology,
L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
April 1991, The Journal of clinical investigation,
L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
May 2004, European journal of pharmacology,
L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
October 1990, Experientia,
L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
February 1985, Research communications in chemical pathology and pharmacology,
L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
May 1995, Journal of cardiovascular pharmacology,
L Phivthong-ngam, and S M Bode-Böger, and R H Böger, and M Böhme, and R P Brandes, and A Mügge, and J C Frölich
January 2000, Life sciences,
Copied contents to your clipboard!